SKF-77,434 Referências Menu de navegação104422-04-012411204878338210.1007/BF022494079336305108694061159444810.1007/s0021301007791191966310.1007/s00213-001-0976-z1600021710.1016/j.pbb.2005.06.0061691494810.1097/01.fbp.0000205015.67079.f7

!Páginas que usam predefinições depreciadasAgonistas da dopaminaAlquenos


agonistas parciaisdopaminérgicos
D1estimulantesanorécticoseficáciaSKF-81,2976-Br-APBcocaína































Estrutura química de SKF-77,434

SKF-77,434
Star of life caution.svg Aviso médico


Nome IUPAC (sistemática)

3-alilo-1-fenil-1,2,4,5-tetraidro-3-benzazepino-7,8-diol

Identificadores

CAS

104422-04-0

ATC
?

PubChem

1241

ChemSpider

1204

Informação química

Fórmula molecular

C19H21NO2 

Massa molar
295.375 g/mol

SMILES
c3ccccc3C2CN(CC=C)CCc(cc1O)c2cc1O

Farmacocinética

Biodisponibilidade
?

Metabolismo
?

Meia-vida
?

Excreção
?

Considerações terapêuticas

Administração
?

DL50
?

SKF-77,434 é um fármaco que atua como um dos agonistas parciais dopaminérgicos
D1 e tem efeitos estimulantes e anorécticos. Ao contrário doutros agonistas D1 com maior eficácia tal como o SKF-81,297 e o 6-Br-APB, o SKF-77,434 não mantém a auto-administração em estudos com animais, e tem sido estudado como uma potencial cura para o vício da cocaína.[1][2][3][4][5][6][7]



Referências



  1. Grech, D. M.; Spealman, R. D.; Bergman, J. (1996). «Self-administration of D1 receptor agonists by squirrel monkeys». Psychopharmacology. 125 (2): 97–104. PMID 8783382. doi:10.1007/BF02249407 


  2. Weed, M. R.; Paul, I. A.; Dwoskin, L. P.; Moore, S. E.; Woolverton, W. L. (1997). «The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys». The Journal of Pharmacology and Experimental Therapeutics. 283 (1): 29–38. PMID 9336305 


  3. Platt, D. M.; Rowlett, J. K.; Spealman, R. D. (2000). «Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434». The Journal of Pharmacology and Experimental Therapeutics. 293 (3): 1017–1026. PMID 10869406 


  4. Platt, D. M.; Rowlett, J. K.; Spealman, R. D. (2001). «Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys». Psychopharmacology. 157 (2): 208–216. PMID 11594448. doi:10.1007/s002130100779 


  5. Mutschler, N. H.; Bergman, J. (2002). «Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys». Psychopharmacology. 160 (4): 362–370. PMID 11919663. doi:10.1007/s00213-001-0976-z 


  6. Desai, R. I.; Terry, P.; Katz, J. L. (2005). «A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice». Pharmacology, Biochemistry, and Behavior. 81 (4): 843–848. PMID 16000217. doi:10.1016/j.pbb.2005.06.006 


  7. Katz, J. L.; Kopajtic, T. A.; Terry, P. (2006). «Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats». Behavioural Pharmacology. 17 (4): 303–309. PMID 16914948. doi:10.1097/01.fbp.0000205015.67079.f7 








Popular posts from this blog

Are there any AGPL-style licences that require source code modifications to be public? Planned maintenance scheduled April 23, 2019 at 23:30 UTC (7:30pm US/Eastern) Announcing the arrival of Valued Associate #679: Cesar Manara Unicorn Meta Zoo #1: Why another podcast?Force derivative works to be publicAre there any GPL like licenses for Apple App Store?Do you violate the GPL if you provide source code that cannot be compiled?GPL - is it distribution to use libraries in an appliance loaned to customers?Distributing App for free which uses GPL'ed codeModifications of server software under GPL, with web/CLI interfaceDoes using an AGPLv3-licensed library prevent me from dual-licensing my own source code?Can I publish only select code under GPLv3 from a private project?Is there published precedent regarding the scope of covered work that uses AGPL software?If MIT licensed code links to GPL licensed code what should be the license of the resulting binary program?If I use a public API endpoint that has its source code licensed under AGPL in my app, do I need to disclose my source?

2013 GY136 Descoberta | Órbita | Referências Menu de navegação«List Of Centaurs and Scattered-Disk Objects»«List of Known Trans-Neptunian Objects»

Button changing it's text & action. Good or terrible? The 2019 Stack Overflow Developer Survey Results Are Inchanging text on user mouseoverShould certain functions be “hard to find” for powerusers to discover?Custom liking function - do I need user login?Using different checkbox style for different checkbox behaviorBest Practices: Save and Exit in Software UIInteraction with remote validated formMore efficient UI to progress the user through a complicated process?Designing a popup notice for a gameShould bulk-editing functions be hidden until a table row is selected, or is there a better solution?Is it bad practice to disable (replace) the context menu?